Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Clinical trial NCT03628612 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT03628612
Sponsor: Autolus Limited
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy Multiple Myeloma DLBCL ALL, Adult and Pediatric T Cell Lymphoma

Start date: 2018-08-02
Primary completion: 2043-07-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.